Brazil Biopharmaceutical Cmo And Cro Market Size & Outlook
Brazil biopharmaceutical cmo and cro market, 2017-2030 (US$M)
Related Markets
Brazil biopharmaceutical cmo and cro market highlights
- The Brazil biopharmaceutical cmo and cro market generated a revenue of USD 282.2 million in 2021 and is expected to reach USD 755.1 million by 2030.
- The Brazil market is expected to grow at a CAGR of 11.6% from 2022 to 2030.
- In terms of segment, mammalian was the largest revenue generating source in 2021.
- Non-mammalian is the most lucrative source segment registering the fastest growth during the forecast period.
Biopharmaceutical cmo and cro market data book summary
| Market revenue in 2021 | USD 282.2 million |
| Market revenue in 2030 | USD 755.1 million |
| Growth rate | 11.6% (CAGR from 2021 to 2030) |
| Largest segment | Mammalian |
| Fastest growing segment | Non-mammalian |
| Historical data | 2017 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Mammalian, Non-mammalian |
| Key market players worldwide | Boehringer Ingelheim, Lonza Group Ltd, Innovent Biologics Inc, Rentschler Biopharma SE, JRS Pharma, AGC Inc, Probiogen, FUJIFILM Holdings Corp, Toyobo Co Ltd, Samsung BioLogics, Thermo Fisher Scientific Inc, R1 RCM Inc, WuXi Biologics (Cayman) Inc, AbbVie Inc, Binex, Charles River Laboratories International Inc, Icon PLC, PAREXEL, Labcorp Holdings Inc |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.0% of the global biopharmaceutical cmo and cro market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil biopharmaceutical cmo and cro market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 755.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical CMO And CRO Market Scope
Biopharmaceutical CMO And CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil biopharmaceutical cmo and cro market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical cmo and cro market will help companies and investors design strategic landscapes.
Mammalian was the largest segment with a revenue share of 60.17% in 2021. Horizon Databook has segmented the Brazil biopharmaceutical cmo and cro market based on mammalian, non-mammalian covering the revenue growth of each sub-segment from 2017 to 2030.
The Brazilian market of biopharmaceutical CMOs & CROs is expected to witness considerable growth accounted for 11.3% over the forecast period owing to presence of high untapped potential in the country.
These initiatives are aimed at increasing investments in the production of active pharmaceutical ingredients and biologics. Moreover, the government’s current goal to ensure GMP compliance among small- and medium-sized pharma companies is anticipated to encourage growth in the country.
Moreover, presence of numerous GMP-certified plants and low manufacturing costs are attracting investors from other regions to establish their operations in this country, which is expected to drive the growth of Brazilian biopharmaceutical market.
Reasons to subscribe to Brazil biopharmaceutical cmo and cro market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil biopharmaceutical cmo and cro market databook
-
Our clientele includes a mix of biopharmaceutical cmo and cro market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil biopharmaceutical cmo and cro market , including forecasts for subscribers. This country databook contains high-level insights into Brazil biopharmaceutical cmo and cro market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil biopharmaceutical cmo and cro market size, by source, 2017-2030 (US$M)
Brazil Biopharmaceutical CMO And CRO Market Outlook Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
